bpc-157 prostate Multifunctionality and Possible Medical Application of the BPC 157 Peptide—Literature and Patent Review Prostamax - Injectable Peptide
Description
This is normal and does not indicate degradation
Clinical evidence is limited but increasing
Can a dietary/nutritional supplement company have their supplements tested by WADA
The economics of pharmaceutical development do create real evidence gaps for unpatentable molecules, and patients pay the cost of that asymmetry
Requires more pills to see effective results
